Union Minister Piyush Goyal announced that the Central Government is evaluating 100 percent funding support for medical testing equipment manufacturing. The initiative aims to reduce import dependence, lower diagnostic costs, and position India as a self-reliant global hub for advanced medical technology and healthcare infrastructure.
NEW DELHI — Union Minister of Commerce and Industry Piyush Goyal indicated that the Central Government is actively evaluating proposals to provide 100 percent funding support for advanced medical testing equipment manufacturing. Speaking at an industry interaction in New Delhi, the minister emphasized the critical need to bolster domestic medical device infrastructure, reduce import dependence, and enhance healthcare accessibility across Tier-2 and Tier-3 regions.
The prospective policy initiative aligns with broader national efforts to establish India as a global manufacturing hub for specialized healthcare hardware. By subsidizing capital expenditure and research-and-development outlays for high-precision diagnostic instruments, the administration aims to lower healthcare delivery costs while strengthening domestic supply chain resilience.
Expanding Domestic Manufacturing and MedTech Infrastructure
India's medical device sector currently relies heavily on imported diagnostic and testing machinery, posing supply vulnerabilities during global trade disruptions. Introducing comprehensive funding support is designed to encourage domestic enterprises and joint ventures to scale up localized fabrication lines for computed tomography (CT) scanners, magnetic resonance imaging (MRI) components, and automated laboratory testing apparatus.
Industry associations have consistently advocated for targeted capital incentives to offset high initial setup costs and specialized component sourcing challenges. Under the proposed framework, central financial assistance could cover machinery acquisition, cleanroom establishment, and testing compliance infrastructure, accelerating commercial readiness for domestic medtech innovators.
According to ministerial briefings, industry consultative notes, and policy reviews:
Proposed Support: Up to 100 percent financial funding mechanisms for specialized medical testing equipment manufacturing facilities.
Strategic Objective: Reducing import dependency on critical diagnostic machinery and fostering domestic R&D.
Target Sectors: Diagnostic imaging systems, pathology testing instruments, and point-of-care medical devices.
Target Beneficiaries: Domestic manufacturers, medical technology startups, and joint-venture industrial units.
Official Sources Section
Quote Section
"According to official statements from Union Minister Piyush Goyal, the government is exploring robust financial support models to encourage domestic manufacturing of advanced medical testing equipment and strengthen national healthcare resilience."
Why It Matters
For healthcare providers and patients across India, localized production of diagnostic machinery reduces equipment acquisition costs, which translates to more affordable medical testing and diagnostics. For industrial investors and medtech manufacturers, 100 percent central funding support minimizes financial barriers, unlocking long-term growth opportunities within India's expanding healthcare market.
Key Facts at a Glance
Key Spokesperson: Union Minister Piyush Goyal.
Focus Area: Medical testing equipment manufacturing and diagnostic infrastructure.
Policy Goal: Enhancing self-reliance in high-precision healthcare hardware.
Expected Outcome: Lower capital hurdles for domestic medtech producers.
FAQ Section
What did Union Minister Piyush Goyal propose regarding medical testing equipment?
The minister indicated that the Central Government is considering 100 percent funding support to boost the domestic manufacturing of medical testing and diagnostic equipment.
Why is local manufacturing of medical devices important for India?
Local manufacturing reduces heavy reliance on imported diagnostic machinery, lowers healthcare infrastructure costs, and strengthens national supply chain security.
Which sectors of the healthcare industry will benefit from this initiative?
Domestic medtech manufacturers, diagnostic equipment producers, and healthcare startups focusing on precision testing apparatus stand to benefit.
Where can stakeholders track official updates on medical device policies?
Policy announcements and industrial incentive guidelines are published via the Ministry of Commerce and Industry Portal.
Source: Ministry of Commerce and Industry, Ministry of Health and Family Welfare, The Economic Times Healthcare Desk, Mint Industry Bureau